AD-2132
- Generic Name
- AD-2132
A Study to Compare PK, PD and Safety of the AD-213-B and AD-2132
- First Posted Date
- 2021-02-16
- Last Posted Date
- 2021-08-06
- Lead Sponsor
- Addpharma Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT04755985
- Locations
- 🇰🇷
Young-Ran Yoon, Daegu, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath